{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:06:45Z","timestamp":1789657605536,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001262","name":"National Parkinson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000887","name":"Huntington Disease Society of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000887","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.parkreldis.2018.04.037","type":"journal-article","created":{"date-parts":[[2018,5,5]],"date-time":"2018-05-05T19:21:46Z","timestamp":1525548106000},"page":"37-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["DAT-SPECT imaging in cases of drug-induced parkinsonism in a specialty movement disorders practice"],"prefix":"10.1016","volume":"53","author":[{"given":"Jacob","family":"Yomtoob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4138-6531","authenticated-orcid":false,"given":"Kimberly","family":"Koloms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Bega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2018.04.037_bib1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.arr.2015.12.009","article-title":"Molecular imaging of dopamine transporters","volume":"30","author":"Brooks","year":"2016","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.parkreldis.2018.04.037_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000370116","article-title":"Is there a role for DAT-SPECT imaging in a specialty movement disorders practice?","volume":"15","author":"Bega","year":"2015","journal-title":"Neurodegener. Dis."},{"issue":"8","key":"10.1016\/j.parkreldis.2018.04.037_bib3","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.57.8.1497","article-title":"Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease","volume":"57","author":"Hughes","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2018.04.037_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/jnnp.2008.157370","article-title":"The role of DAT-SPECT in movement disorders","volume":"81","author":"Kagi","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"1","key":"10.1016\/j.parkreldis.2018.04.037_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3988\/jcn.2012.8.1.15","article-title":"Drug-induced parkinsonism","volume":"8","author":"Shin","year":"2012","journal-title":"J. Clin. Neurol. (Seoul, Korea)"},{"issue":"6","key":"10.1016\/j.parkreldis.2018.04.037_bib6","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.52.6.1214","article-title":"Incidence and distribution of parkinsonism in olmsted county, Minnesota, 1976-1990","volume":"52","author":"Bower","year":"1999","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.parkreldis.2018.04.037_bib7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/mds.20806","article-title":"Parkinsonism and Parkinson's disease in the elderly: a community-based survey in Brazil (the Bambui study)","volume":"21","author":"Barbosa","year":"2006","journal-title":"Mov. Disord. Offic. J. Mov. Dis. Soc."},{"issue":"3","key":"10.1016\/j.parkreldis.2018.04.037_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/mds.10362","article-title":"Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain","volume":"18","author":"Benito-Leon","year":"2003","journal-title":"Mov. Disord. Offic. J. Mov. Dis. Soc."},{"issue":"2","key":"10.1016\/j.parkreldis.2018.04.037_bib9","first-page":"269","article-title":"Clinical features of drug-induced parkinsonism based on [18F] FP-CIT positron emission tomography","volume":"36","author":"Shin","year":"2015","journal-title":"Neurol. Sci. Offic. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"issue":"7","key":"10.1016\/j.parkreldis.2018.04.037_bib10","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.parkreldis.2014.03.024","article-title":"Motor and non-motor features of Parkinson's disease that predict persistent drug-induced parkinsonism","volume":"20","author":"Morley","year":"2014","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2018.04.037_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1212\/WNL.46.1.231","article-title":"[123I] beta-CIT\/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-parkinson's disease","volume":"46","author":"Marek","year":"1996","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.parkreldis.2018.04.037_bib12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/mds.10482","article-title":"Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations","volume":"18","author":"Benamer","year":"2003","journal-title":"Mov. Disord. Offic. J. Mov. Dis. Soc."},{"issue":"7","key":"10.1016\/j.parkreldis.2018.04.037_bib13","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00259-008-0777-2","article-title":"The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism","volume":"35","author":"Van Laere","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"10","key":"10.1016\/j.parkreldis.2018.04.037_bib14","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/mds.20112","article-title":"Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes","volume":"19","author":"Catafau","year":"2004","journal-title":"Mov. Disord. Offic. J. Mov. Dis. Soc."},{"issue":"12","key":"10.1016\/j.parkreldis.2018.04.037_bib15","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00259-002-0938-7","article-title":"Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand","volume":"29","author":"Lokkegaard","year":"2002","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"1","key":"10.1016\/j.parkreldis.2018.04.037_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.parkreldis.2014.10.022","article-title":"Experience with DaTscan at a tertriary referral center","volume":"21","author":"Sadasivan","year":"2015","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2018.04.037_bib17","first-page":"29","article-title":"The impact of DaTscan on the diagnosis and management of movement disorders: a retrospective study","volume":"2","author":"Seifert","year":"2013","journal-title":"Am. J. Neurodegen. Dis."},{"issue":"4","key":"10.1016\/j.parkreldis.2018.04.037_bib18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.20748","article-title":"[123I]-FP\/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease","volume":"21","author":"Lorberboym","year":"2006","journal-title":"Mov. Disord. Offic. J. Mov. Dis. Soc."},{"issue":"15","key":"10.1016\/j.parkreldis.2018.04.037_bib19","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/mds.22805","article-title":"Levosulpiride-induced movement disorders","volume":"24","author":"Shin","year":"2009","journal-title":"Mov. Disord. Offic. J. Mov. Dis. Soc."},{"issue":"12","key":"10.1016\/j.parkreldis.2018.04.037_bib20","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.3109\/00207450903225553","article-title":"Movement disorders associated with aripiprazole use: a case series","volume":"119","author":"Hall","year":"2009","journal-title":"Int. J. Neurosci."},{"issue":"1","key":"10.1016\/j.parkreldis.2018.04.037_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/NRL.0000000000000096","article-title":"Movement disorders induced by the \"atypical\" antipsychotic aripiprazole","volume":"22","author":"Selfani","year":"2017","journal-title":"Neurologist"},{"issue":"6","key":"10.1016\/j.parkreldis.2018.04.037_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.amjopharm.2012.11.001","article-title":"Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex","volume":"10","author":"Marras","year":"2012","journal-title":"Am. J. Geriatr. Pharmacother."},{"issue":"8","key":"10.1016\/j.parkreldis.2018.04.037_bib23","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.parkreldis.2013.03.016","article-title":"Valproic acid-induced parkinsonism: levodopa responsiveness with dyskinesia","volume":"19","author":"Silver","year":"2013","journal-title":"Park. Relat. Disord."},{"issue":"12","key":"10.1016\/j.parkreldis.2018.04.037_bib24","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/mds.23828","article-title":"Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France","volume":"26","author":"Bondon-Guitton","year":"2011","journal-title":"Mov. Disord. Offic. J. Mov. Dis. Soc."},{"issue":"1","key":"10.1016\/j.parkreldis.2018.04.037_bib25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/mds.21188","article-title":"Valproate-induced Parkinsonism in epilepsy patients","volume":"22","author":"Jamora","year":"2007","journal-title":"Mov. Disord. Offic. J. Mov. Dis. Soc."},{"issue":"12","key":"10.1016\/j.parkreldis.2018.04.037_bib26","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1017\/S1041610216001101","article-title":"A case of lithium-induced parkinsonism presenting with typical motor symptoms of Parkinson's disease in a bipolar patient","volume":"28","author":"Hermida","year":"2016","journal-title":"Int. Psychogeriatr."},{"issue":"2\u20133","key":"10.1016\/j.parkreldis.2018.04.037_bib27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.schres.2013.11.028","article-title":"Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study","volume":"152","author":"Tinazzi","year":"2014","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.parkreldis.2018.04.037_bib28","doi-asserted-by":"crossref","first-page":"e0157410","DOI":"10.1371\/journal.pone.0157410","article-title":"Persistent drug-induced parkinsonism in patients with normal dopamine transporter imaging","volume":"11","author":"Hong","year":"2016","journal-title":"PLoS One"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802018302219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802018302219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:14:55Z","timestamp":1761178495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802018302219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":28,"alternative-id":["S1353802018302219"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.04.037","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DAT-SPECT imaging in cases of drug-induced parkinsonism in a specialty movement disorders practice","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.04.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}